Source Nature · Published · Open the original ↗
Labs
Anthropic bought a one-person, AI-powered biotech: is this drug discovery’s future?
A promising biotechnology company developed an approach that might treat a rare disease, but its sole employee didn’t do all the work.
The question came to the fore after news that a biotechnology company armed with an artificial-intelligence assistant , two promising drug leads and just one full-time human employee had been acquired by San Francisco-based Anthropic as part of the AI giant’s expansion into biomedical science .
The opening of the report, quoted unchanged from Nature. The full text continues at the source.